5[1]Woerdenbag HJ, Moskal TA, Pras N, Malingre TM, el-Feraly FS, Kampinga HH, et al. Cytotoxicity of arte misinin-related endoperoxides to Ehrlich ascites tumor cells [J]. J Nat Prod,1993; 56(6): 849- 56
6[3]Li Y, Shan F, Wu JM, Wu GS, Ding J, Xiao D, et al. Novel antitumor artemisinin derivatives targeting G1 phase of the cell cycle[J]. Bioorg Med Chem Lett, 2001;11(1):5- 8
7[7]Singh NP, Lai H. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells[J]. Life Sciences, 2001;70(1):49- 56
8[8]Moore JC, Lai H, Li JR, Ren RL, McDougall JA, Singh NP,et al. Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat[J]. Cancer Lett, 1995;98(1):83- 7
9[9]Lai H, Singh NP. Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin [J]. Cancer Lett,1995;91(1) :41 - 6
10[10]Olie RA, Simoes-Wust AP, Baunann B, Leech SH, Fabbro D, Stahel RA, et al. A novel antisense oligonucleotide targeting surviving expression induces apoptosis and sensitizes lung cancer cells to chemotherapy[J]. Cancer Res, 2000; 60 (11):2805 - 9
